drugset / Trial / NCT05728541
Dose Escalation and Expansion Study of SYH2043 in Patients With Advanced Malignant Tumors
NaSingle-groupOpen-labelTreatment
Summary
The aim of this study is designed to evaluate the safety, tolerability, pharmacokinetics, and preliminary antitumor activity of SYH2043 in patients with advanced malignant tumors.
Timeline
- Start
- 2023-03-01
- Primary completion
- 2026-02-01
- Completion
- 2026-03-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SYH2043 | Unknown | — | — |